Current status of ex vivo liver resection and autotransplantation in treatment of benign liver lesions
- VernacularTitle:离体肝切除联合自体肝移植在肝脏良性病变中的治疗现状
- Author:
Shuai ZHANG
1
;
Fazhu FEI
1
;
Zhixin WANG
1
;
Haining FAN
1
;
Haijiu WANG
1
;
Lizhao HOU
1
Author Information
- Publication Type:Review
- Keywords: Hepatectomy; Liver Transplantation; Liver Diseases
- From: Journal of Clinical Hepatology 2024;40(12):2543-2547
- CountryChina
- Language:Chinese
- Abstract: Benign liver lesions mainly include hepatic hemangioma， focal nodular hyperplasia of the liver， hepatocellular adenoma， and hepatic angiomyolipoma. Hepatic alveolar echinococcosis is a type of parasitic disease， and since it mainly occurs in the liver， it is also a benign lesion of the liver. The clinical treatment of benign liver lesions is mainly based on follow-up observation， supplemented by surgical resection. For patients with end-stage diseases， liver transplantation can be performed due to the large volume of the lesion， the invasion of a number of surrounding large vessels， unclear anatomic location， and the possibility of intraoperative rupture and massive hemorrhage. Since patients with poor liver function based on the liver allocation score for organ donation are more likely to get donor liver， it is difficult for patients with benign liver lesions to obtain the corresponding donor liver resources due to the growth pattern of benign liver lesions， thereby leading to the limited application of allogeneic liver transplantation. Since its emergence in the 1980s， ex vivo liver resection and autotransplantation （ELRA） has brought a new way for the treatment of such patients. This article summarizes the current application of ELRA in benign liver lesions， in order to provide a reference for diagnosis and treatment by clinical medical staff.
